What you need to know

Regular testing (at least annually) for albuminuria with urine albumin-creatine ration (UACR) is recommended for risk stratification in patients with or at risk for chronic kidney disease (CKD), including those with diabetes, hypertension, and/or cardiovascular disease

In epidemiological studies, a >30% reduction in albuminuria was associated with up to 56% lower risk of kidney failure and 28% lower risk of cardiovascular disease

Antiproteinuric therapies are recommended for treatment of CKD by clinical guidelines including KDIGO. Consider angiotensin receptor blockers, angiotensin converting enzyme inhibitors, sodium glucose co-transporter 2 inhibitors, non-steroidal mineralocorticoid receptor antagonists, or glucagon-like peptide receptor agonists, depending on t

See Full Page